Latest filing published 08 Jun 2026 for Indivior Pharmaceuticals, Inc., €1.2M.
No signal scores available.
This profile gathers the share dealings of Preblick Ryan in Indivior Pharmaceuticals, Inc. Altogether 2 filings, all relating to 8 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 8 June 2026: a transaction of €1.2M, in Indivior Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration